Erythropoietin Receptor (EpoR) Agonism Is Used to Treat a Wide Range of Disease

• Hauptverfasser: Fabian Sanchis-Gomar (Verfasst von), Carme Perez-Quilis (Verfasst von), Giuseppe Lippi (Verfasst von)
• Format: Buch
• Veröffentlicht: BMC, 2013-04-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Abstract The erythropoietin receptor (EpoR) was discovered and described in red blood cells (RBCs), stimulating its proliferation and survival. The target in humans for EpoR agonists drugs appears clear-to treat anemia. However, there is evidence of the pleitropic actions of erythropoietin (Epo). Fo...